Detalhe da pesquisa
1.
Patient Perspectives on the Benefits and Challenges of Diabetes and Digital Technology.
Clin Diabetes
; 42(2): 243-256, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38666210
2.
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.
Cardiovasc Diabetol
; 22(1): 59, 2023 03 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36927451
3.
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial.
Diabetes Obes Metab
; 25(2): 545-555, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36263928
4.
Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey.
Diabetes Obes Metab
; 20(2): 301-308, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28719066
5.
CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes.
J Autoimmun
; 50: 77-82, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24387802
6.
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design.
Diabetes Ther
; 11(8): 1907-1908, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32578133
7.
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design.
Diabetes Ther
; 11(7): 1607-1608, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32361833
8.
InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design.
Diabetes Ther
; 11(4): 1017-1027, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32100192
9.
Burden of Cardiovascular Disease in Adult Patients with Type 1 Diabetes in the US.
Pharmacoecon Open
; 4(3): 519-528, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31997126
10.
Higher proinflammatory cytokine production and spontaneous activation in some type 1 and type 2 diabetic subjects.
Clin Immunol
; 155(1): 27-29, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25173803
11.
Reference Guide for Integrating Continuous Glucose Monitoring Into Clinical Practice.
Diabetes Educ
; 45(1_suppl): 3S-20S, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30541402
12.
New therapeutic options for treating type-2 diabetes: a review of insulin analogs and premixed insulin analogs.
J Natl Med Assoc
; 99(4): 357-60, 363-7, 2007 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-17444424
13.
A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes.
Diabetes Care
; 29(10): 2189-95, 2006 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-17003291
14.
Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Glucagon-Like Peptide-1 Receptor Agonists.
J Fam Pract
; 66(10 Suppl): S12-S16, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28991932
15.
AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes.
Diabetes Care
; 37(8): 2132-40, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24742662
16.
Comparative Assessment of Lixisenatide, Exenatide, and Liraglutide Pen Devices: A Pilot User-Based Study.
J Diabetes Sci Technol
; 8(1): 123-131, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24876548
17.
Impact of Biosimilar Insulins on Clinical Practice: Meeting Report.
J Diabetes Sci Technol
; 8(1): 179-185, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24876554
18.
Temporal intra-individual variation of immunological biomarkers in type 1 diabetes patients: implications for future use in cross-sectional assessment.
PLoS One
; 8(11): e79383, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-24223938
19.
Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?
Nat Clin Pract Endocrinol Metab
; 3(5): E1; discussion E2, 2007 May.
Artigo
Inglês
| MEDLINE | ID: mdl-17452962
20.
Response to comment on Edelman et al. AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes. Diabetes Care 2014;37:2132-2140.
Diabetes Care
; 37(12): e263-4, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25414399